Zhiying Shan received her Ph.D. training at the Institute of Molecular Biology, Nankai University of China from 2001 to 2004. She started her postdoctoral training in Dr. Raizada’s laboratory in 2005. She has initiated and developed two major research projects; (i) role of brain prorenin receptor (PRR) in the control of cardiovascular function, which mainly focuses on the physiological relevance of overexpression/chronic knockdown PRR in the cardiovascular control brain areas, including the supraoptic nucleus (SON) and the nucleus of the solitary tract (NTS). (ii) The effect of knockdown brain angiotensin II type I receptors in hypertension. This utilizes AAV-mediated shRNA delivery techniques to determine a long-term reversal of hypertension. Dr. Shan has broad expertise in molecular, cellular, and microbiology. In addition, she has extensive experience of AAV and lenti-vector construction.